Precision Optics (NASDAQ:POCI) Announces Quarterly Earnings Results

Precision Optics logo with Healthcare background
Image from MarketBeat Media, LLC.

Precision Optics (NASDAQ:POCI - Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.09, Zacks reports. Precision Optics had a negative return on equity of 23.92% and a negative net margin of 11.51%.

Here are the key takeaways from Precision Optics' conference call:

  • Revenue and profitability improved year over year: First-quarter revenue rose 22% to $8.2 million, gross margin increased to 22.5% from 14.2%, and adjusted EBITDA loss narrowed to about $200,000 from $1.2 million. Management attributed the gains to higher production volumes and improved manufacturing efficiency.
  • The satellite customer’s pullback will weigh on near-term results: Revenue from the program fell 39% sequentially to $2.3 million, and management expects about $1.2 million in the December quarter, with a larger adjusted EBITDA loss than in Q1. The company expects shipments to recover to roughly $2 million in each of Q3 and Q4 after receiving a follow-on order.
  • Fiscal 2027 guidance is unchanged at $30 million–$33 million in revenue and an adjusted EBITDA loss of $1.2 million–$1.7 million; management expects a strong second-half recovery after the anticipated Q2 trough.
  • New medical-device programs are moving into production: Two programs have started production, with two more expected to follow within six to nine months. Management estimates the four programs together could reach a $1.5 million–$2 million annual run rate by fiscal year-end and eventually contribute about $5 million–$6 million annually.
  • A second satellite program remains a longer-term growth opportunity, but its production timing has shifted: Production is now anticipated in Q4 of calendar 2028. The company also described potential additional satellite and adjacent-market opportunities, while noting that some of these markets are still developing.

Precision Optics Trading Down 5.0%

Shares of POCI traded down $0.26 during mid-day trading on Monday, reaching $4.97. The company had a trading volume of 32,016 shares, compared to its average volume of 39,436. Precision Optics has a fifty-two week low of $3.55 and a fifty-two week high of $6.15. The firm has a fifty day simple moving average of $4.53 and a 200-day simple moving average of $4.64. The stock has a market cap of $54.64 million, a price-to-earnings ratio of -10.80 and a beta of 0.23. The company has a current ratio of 2.28, a quick ratio of 1.84 and a debt-to-equity ratio of 0.03.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on POCI shares. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Precision Optics in a research report on Wednesday, September 2nd. Wall Street Zen upgraded Precision Optics to a "hold" rating in a research note on Saturday, October 3rd. One analyst has rated the stock with a Sell rating. According to MarketBeat, the company presently has a consensus rating of "Sell".

Check Out Our Latest Analysis on Precision Optics

Precision Optics Company Profile

(Get Free Report)

Precision Optics Corporation, Inc. designs and manufactures optical systems and components for medical, defense, aerospace and industrial applications. Its work spans product development, prototyping, engineering and production for customers seeking specialized imaging solutions. The company's products include rigid and flexible endoscopes, three-dimensional endoscopic imaging systems, micro-optics and other precision optical assemblies. Its offerings support medical-device makers and other organizations that need compact, high-performance imaging equipment.

Read More

Earnings History for Precision Optics (NASDAQ:POCI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Precision Optics Right Now?

Before you consider Precision Optics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Precision Optics wasn't on the list.

While Precision Optics currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines